Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Kantonsspital Graubuenden (Site 2103)

Chur, Kanton Graubünden 7000, SwitzerlandNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Lung cancer

Closed trials

Completed
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)
NCT03516981· Phase 2· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Kantonsspital Graubuenden (Site 2103): trial site – Frontlight Research